Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens [28]

Nature

Volumn 265, Issue 5596, 1977, Pages 750-751

  Schultz, Klaus Dieter ^a   Schultz, Karin ^a   Schultz, Günter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALCOHOL; CALCIUM CHLORIDE; CHLORPROMAZINE; CINNARIZINE; CYCLIC GMP; DIAZOXIDE; DIPYRIDAMOLE; EDETIC ACID; GLYCERYL TRINITRATE; HYDRALAZINE; HYDROXYLAMINE; LIDOFLAZINE; MINOXIDIL; MUSCLE RELAXANT AGENT; NITROPRUSSIDE SODIUM; PENTOBARBITAL; PERHEXILINE; PHENYTOIN; PRENYLAMINE; PROADIFEN; SODIUM NITRITE; TETRACAINE; VERAPAMIL DERIVATIVE;

IN VITRO STUDY; RAT; SMOOTH MUSCLE; SMOOTH MUSCLE RELAXATION; SPERMATIC CORD; THEORETICAL STUDY;

ANIMAL; ANTIHYPERTENSIVE AGENTS; CALCIUM; CYCLIC AMP; CYCLIC GMP; FERRICYANIDES; MALE; MUSCLE, SMOOTH; NITROPRUSSIDE; PARASYMPATHOLYTICS; RATS; VAS DEFERENS;

EID: 0017360713     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/265750a0     Document Type: Letter

References (26)

1. Somlyo, A. P. & Somlyo, A. V. Pharmacol. Rev. 22, 249-353 (1970).
2. Hurwitz, L. & Suria, A. A. Rev. Pharmacol. 11, 303-326 (1971).
3. Bär, H. P. Adv. Cycl. Nucl. Res. 4, 195-237 (1974).
4. Schultz, G. & Hardman, J. G. in Eukaryotic Cell Function and Growth (eds Dumont, J. E., Brown, B. L. & Marshall, N. J.) 667-683 (Plenum, New York, 1976).
5. Lee, T.-P., Kuo, J. F. & Greengard, P. Proc. natn. Acad. Sci. U.S.A. 69, 3287-3291 (1972).
6. Dunham, E. W., Haddox, M. K. & Goldberg, N. D. Proc. natn. Acad. Sci. U.S.A. 71, 815-819 (1974).
7. Andersson, R. et al. Adv. Cycl. Nucl. Res. 5, 491-518 (1975).
8. Schultz, G., Hardman, J. G., Schultz, K., Baird, C. E. & Sutherland, E. W. Proc. natn. Acad. Sci. U.S.A. 70, 3889-3893 (1973).
9. Schultz, G. & Hardman, J. G. Adv. Cycl. Nucl. Res. 5, 339-351 (1975).
10. Schultz, G., Schultz, K. & Hardman, J. G. Metabolism 24, 429-437 (1975).
11. Schultz, G. in Asthma II Physiology Immunopharmacology and Treatment (eds Austen, K. F. & Lichtenstein, L. M.) (Academic, New York, 1977).
12. Diamond, J. & Hartle, D. K. Canad. J. Physiol. Pharmacol. 52, 763-767 (1974).
13. Diamond, J. & Holmes, T. G. Canad. J. Physiol. Pharmacol. 53, 1099-1107 (1975).
14. Clyman, R. I., Sandler, J. A., Manganiello, V. & Vaughan, M. J. clin. Invest. 55, 1020-1025 (1975).
15. Diamond, J. & Hartle, D. K. J. Cycl. Nucl. Res. 2, 179-188 (1976).
16. Diamond, J. & Blisard, K. S. Molec. Pharmacol. 12, 688-692 (1976).
17. Kreye, V. A. W., Baron, G. D., Lüth, J. B. & Schmidt-Gayk, H. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 381-402 (1975).
18. Hurwitz, L. & Joiner, P. D. Am. J. Physiol. 218, 12-19 (1970).
19. Schultz, G., Hardman, J. G., Schultz, K., Davis, J. W. & Sutherland, E. W. Proc. natn. Acad. Sci. U.S.A. 70, 1721-1725 (1973).
20. Kimura, H., Mittal, C. K. & Murad, F. Nature 257, 700-702 (1975).
21. Katsuki, S. & Murad, F. Pharmacologist 18, 220, (1976).
22. De Rubertis, F. R. & Craven, P. A. Science 193, 897-899 (1976).
23. Pöch, G. & Umfahrer, W. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, 257-268 (1976).
24. Fleckenstein, A., Grün, G., Tritthart, H., Byon, K. & Harding, P. Klin. Wschr. 49, 32-41 (1971).
25. Grün, G. & Fleckenstein, A. Arzneim.-Forsch. 22, 334-344 (1972).
26. Godfraind, T. & Kaba, A. Arch. int. Pharmacodyn. Suppl. 196, 35-49 (1972).